SMCI brings ME/CFS to the thought leaders of precision medicine

Last month, SMCI chief scientific officer and vice president for research, Dr. Zaher Nahle brought together two leading minds in ME/CFS to Duke University to educate the leaders of science and medicine about the scientific opportunity in the field of ME/CFS. Dr. Nahle chaired the exclusive panel called “ME/CFS: The Mysterious Illness Science has Yet to Unravel” with Dr. Anthony Komaroff of Harvard University and John Nicols, president and CEO of Codexis and an SMCI board member.

The Precision Medicine World Conference is the leading forum for personalized medicine, with prominent figures in the biotech industry and academic research drawing over 8,500 attendees. The 2017 conference at Duke University was held in late May. The Solve ME/CFS Initiative (SMCI) organized a panel to discuss Myalgic Encephalomyelitis (ME). The panel, chaired by Solve ME/CFS Initiative’s Chief Scientific Officer Dr. Zaher Nahle, also featured leading expert and SMCI Research Advisory Council member Dr. Anthony Komaroff, and John Nicols, President and CEO of Codexis Inc. and Vice Chair at the SMCI Board of Directors

ME/CFS Patient Janet Flynt

This lively session explored why precision medicine is fundamental in the fight against ME/CFS and how it can be used to understand the elusive etiology of this disease. The panel also sought to challenge researchers to solve this mysterious, debilitating disease. This panel is part of a strategic SMCI effort to educate and recruit talented professionals in biomedical research and technology to find solutions for this disease. Patient perspective was front and center with participation from many patients including Janet Flynt (pictured) who shared here story and provided valuable perspective.

To learn more about this panel, visit:

BioQuick News also published an article discussing the SMCI panel here